ArticleKidney international2012
Renal vitamin D receptor expression and vitamin D renoprotection.
Article in Kidney international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 15 citations in OpenAlex.
- Renal Fanconi syndrome and vitamin D deficiency: chicken or egg?Pediatric nephrology (Berlin, Germany) · 2026Article
- Article
- Comparison of Vitamin D Levels in Premature Infants with and without Retinopathy of Prematurity.Archives of Iranian medicine · 2022Article
- The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy.Endocrine · 2017Article
- Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.Physiological reports · 2016Article
- Vitamin D deficiency and related risk factors in patients with diabetic nephropathy.The Journal of international medical research · 2016Article
- New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease.Oxidative medicine and cellular longevity · 2016Review
- Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.BMC nephrology · 2012Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Therapy to enhance the renoprotective actions of vitamin D receptor (VDR) activation should safely overcome the distinct VDR content along the nephron to effectively control renal calcium reabsorption, control renal klotho levels for the phosphaturic actions of FGF23, and inhibit proteinuria and the activation of the renin-angiotensin system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.